Screening and Monitoring for Infectious Complications When Immunosuppressive Agents Are Studied in the Treatment of Autoimmune Disorders

Journal of the Pediatric Infectious Diseases Society
Brett J LoecheltType 1 Diabetes TrialNet Study Group

Abstract

Significant progress has been made in the development, investigation, and clinical application of immunosuppressive agents to treat a variety of autoimmune disorders. The expansion of clinical applications of these new agents requires the performance of large multicenter clinical trials. These large clinical trials are particularly important as one considers these agents for the treatment of type 1 diabetes, which although autoimmune in its pathogenesis, is not classically treated as an autoimmune disorder. Although these agents hold promise for amelioration or cure of this disease, they have the potential to facilitate infectious complications. There are limited data regarding the prospective assessment of infectious risks with these agents in trials of this nature. Pediatric subjects may be at greater risk due to the higher likelihood of primary infection. A subgroup of experts associated with TrialNet (a National Institutes of Health [NIH]-funded Type 1 diabetes mellitus research network) with expertise in infectious diseases, immunology, and diagnostics developed an approach for screening and monitoring of immunosuppression-associated infections for prospective use in clinical trials. The goals of these recommendations are ...Continue Reading

References

Feb 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C V Paya
May 3, 2002·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Adriana Weinberg
Jun 27, 2002·The Journal of Infectious Diseases·Vincent C EmeryPaul D Griffiths
Jul 24, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·J J Zarranz ImirizalduJ M Corral Carranceja
Jun 11, 2004·The New England Journal of Medicine·Charles F Thomas, Andrew H Limper
Jun 24, 2005·The New England Journal of Medicine·Bart KeymeulenLucienne Chatenoud
Jul 7, 2007·Cancer Investigation·Abraham B SchwarzbergMatthew H Kulke
Jan 10, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter J KrauseAndrew Spielman
Feb 7, 2009·The New England Journal of Medicine·Caroline Breese HallPeter Szilagyi
Jul 10, 2009·The New England Journal of Medicine·Karen M FrankJohn Hart
Aug 8, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Sarah P HammondFrancisco M Marty
May 15, 2010·Infectious Disease Clinics of North America·Sophia KooLindsey R Baden
Oct 19, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Nicolas C IssaLindsey R Baden
Aug 27, 2011·Transplantation·Holenarasipur R VikramJanis E Blair
Oct 9, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brett J LoecheltUNKNOWN Type 1 Diabetes TrialNet Daclizumab/Mycophenolic Acid Study Group
Dec 13, 2012·Transplant Infectious Disease : an Official Journal of the Transplantation Society·S P HammondL R Baden
Feb 15, 2013·The New England Journal of Medicine·Kathryn M EdwardsUNKNOWN New Vaccine Surveillance Network
Mar 8, 2013·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M Green
Mar 22, 2013·The New England Journal of Medicine·Daniel C PayneUmesh D Parashar
Mar 26, 2013·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·W KimH J Kim

❮ Previous
Next ❯

Citations

Mar 9, 2018·Pharmacogenomics·Huan-Yu MengHuan Yang
Apr 29, 2020·Dermatologic Therapy·Claudio ConfortiNicola di Meo
Nov 26, 2020·Jornal de pediatria·Irma Cecília Douglas Paes BarretoAntonio Condino Neto
Jun 24, 2016·Microbiology Spectrum·Andrew Nowalk, Michael Green

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

© 2021 Meta ULC. All rights reserved